Jane Street Group, LLC Fate Therapeutics Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 147,872 shares of FATE stock, worth $248,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,872

Previous 217,739 32.09%

Holding current value

$248,424

Previous $714,000 27.59%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.12 - $5.57 $217,985 - $389,159	-69,867 Reduced 32.09%	147,872 $517,000
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $75,240 - $163,406	23,080 Added 11.86%	217,739 $714,000
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $1.83 Million - $4.31 Million	-516,628 Reduced 72.63%	194,659 $1.43 Million
Q4 2023 Feb 14, 2024	SELL	$1.65 - $3.94 $21,426 - $51,164	-12,986 Reduced 1.79%	711,287 $2.66 Million
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $533,261 - $1.33 Million	263,991 Added 57.35%	724,273 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $1.74 Million - $2.41 Million	365,254 Added 384.36%	460,282 $2.19 Million
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $254,056 - $666,299	-59,919 Reduced 38.67%	95,028 $541,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $1.41 Million - $3.41 Million	143,023 Added 1199.45%	154,947 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $216,101 - $370,372	-10,271 Reduced 46.28%	11,924 $267,000
Q2 2022 Aug 16, 2022	SELL	$17.78 - $42.39 $54,051 - $128,865	-3,040 Reduced 12.05%	22,195 $550,000
Q4 2021 Feb 15, 2022	BUY	$47.84 - $64.34 $462,660 - $622,232	9,671 Added 62.14%	25,235 $1.48 Million
Q3 2021 Nov 16, 2021	SELL	$59.27 - $95.73 $54,054 - $87,305	-912 Reduced 5.54%	15,564 $922,000
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $1.67 Million - $2.29 Million	-24,798 Reduced 60.08%	16,476 $1.43 Million
Q1 2021 May 18, 2021	SELL	$72.16 - $117.4 $1.6 Million - $2.61 Million	-22,214 Reduced 34.99%	41,274 $3.4 Million
Q4 2020 Feb 17, 2021	BUY	$38.09 - $100.95 $758,486 - $2.01 Million	19,913 Added 45.7%	63,488 $5.77 Million
Q3 2020 Nov 17, 2020	BUY	$30.41 - $40.5 $1.08 Million - $1.44 Million	35,593 Added 445.92%	43,575 $1.74 Million
Q2 2020 Aug 17, 2020	SELL	$20.21 - $35.23 $62,428 - $108,825	-3,089 Reduced 27.9%	7,982 $274,000
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $191,306 - $352,943	11,071 New	11,071 $246,000
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $208,375 - $322,600	-15,562 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $4,950 - $7,200	320 Added 2.1%	15,562 $242,000
Q2 2019 Aug 15, 2019	BUY	$15.61 - $20.44 $237,927 - $311,546	15,242 New	15,242 $309,000
Q1 2019 May 16, 2019	SELL	$13.15 - $18.71 $179,576 - $255,503	-13,656 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$11.48 - $16.98 $40,512 - $59,922	3,529 Added 34.85%	13,656 $175,000
Q3 2018 Nov 14, 2018	SELL	$8.75 - $16.29 $752 - $1,400	-86 Reduced 0.84%	10,127 $165,000
Q2 2018 Aug 15, 2018	BUY	$9.16 - $13.48 $93,551 - $137,671	10,213 New	10,213 $116,000
Q4 2017 Feb 15, 2018	SELL	$3.94 - $6.64 $44,490 - $74,978	-11,292 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.6 - $4.31 $29,359 - $48,668	11,292	11,292 $45,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $163M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Fate Therapeutics Inc Transaction History